Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010–2015

Autor: Sandra S. Chaves, Oluwakemi Oni, Nancy M. Bennett, Lisa Miller, Ruth Lynfield, Diane Brady, Mary Lou Lindegren, Marisa Bargsten, Ann Thomas, Shikha Garg, Patricia Ryan, Krista Lung, Pam Daily Kirley, William Schaffner, Grace D. Appiah, Mary Hill, Alicia M. Fry, Shelley M. Zansky, Angela P Campbell, Evan J. Anderson, Seth Eckel, Christie McDonald-Hamm, James Meek
Rok vydání: 2016
Předmět:
Male
0301 basic medicine
Hospitalized patients
Cohort Studies
chemistry.chemical_compound
Influenza A Virus
H1N1 Subtype
0302 clinical medicine
Pandemic
Longitudinal Studies
Prospective Studies
030212 general & internal medicine
Enzyme Inhibitors
Child
education.field_of_study
virus diseases
Middle Aged
Infectious Diseases
Child
Preschool
Female
Seasons
Adult
Microbiology (medical)
medicine.medical_specialty
Oseltamivir
Surveillance data
Adolescent
030106 microbiology
Population
Neuraminidase
Antiviral Agents
Article
Young Adult
03 medical and health sciences
Internal medicine
Influenza
Human
medicine
Humans
Antiviral treatment
education
Pandemics
Aged
Retrospective Studies
business.industry
Infant
Newborn
Infant
Influenza a
Length of Stay
Virology
United States
chemistry
business
Child
Hospitalized
Zdroj: Clinical Infectious Diseases. 64:364-367
ISSN: 1537-6591
1058-4838
Popis: Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010–2011 to 89% in 2014–2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.
Databáze: OpenAIRE
Externí odkaz: